Dr. Jonathan P. Pezanoski, MD

Dr. Pezanoski practices at South Meadows Endoscopy Center in Reno, Nevada.

Dr. Pezanoski's NPI, 1053355545, was assigned on June 15, 2006. Dr. Pezanoski graduated from Royal College of Surgeons Ireland in 2000. Dr. Pezanoski holds Nevada license 12280.

Dr. Pezanoski's primary practice is South Meadows Endoscopy Center, at 10619 Professional Circle, Reno, NV 89521. The practice phone is (775) 852-4848.

Dr. Pezanoski's primary practice is South Meadows Endoscopy Center in Reno, Nevada. Dr. Pezanoski is also affiliated with Renown Regional Medical Center. The medical group on file is Renown Health. Dmand AI also links Dr. Pezanoski to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pezanoski practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Pezanoski's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Pezanoski is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Pezanoski's licenses on file in 4 states: Nevada, Michigan, Wisconsin and Ohio.

Dmand AI lists acid reflux, acute gallbladder or bile duct inflammation, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), colonoscopy, fatty liver and gastroduodenitis among the conditions Dr. Pezanoski treats.

CMS data shows 1,024 Medicare services from Dr. Pezanoski across 22 procedure codes in 2024, for 597 Medicare patients. Medicare paid $117,909 for them.

CMS counts 597 Medicare patients who saw Dr. Pezanoski in 2024. The largest group is 65 to 74, with 363 patients. 75% of them have high cholesterol, and 62% have high blood pressure. 8% are also on Medicaid. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Pezanoski's median patient age at 63, with 54% women.

In 2024, Dr. Pezanoski wrote 850 Medicare Part D claims for 412 patients. 85% of them were for generic drugs. CMS names the drug for 654 of them, across 14 drugs with 11 or more claims each, at $101,230 in total drug cost. In 2023, CMS named 552 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Pezanoski for performance year 2024, reported as part of a group. Dr. Pezanoski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 503 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Pezanoski, more than 98% of the clinicians it reports for that procedure.

CMS Open Payments shows 142 general payments to Dr. Pezanoski from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 87% of the total. Abbvie Inc. paid the most, $1,941.

Dmand AI lists 1 award for Dr. Pezanoski, most recently CMS Stage 1 2012 in 2011.

Dr. Pezanoski graduated from Royal College of Surgeons Ireland in 2000.

Dr. Pezanoski is in network with 16 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.